Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation, 63438-63447 [2021-24918]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
63438
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
and guaranty purchase activities related
to PPP loans.
b. To oversee the performance of
servicing, liquidation, and guaranty
purchase activities of PPP loans by SBA
staff in headquarters and relevant SBA
loan centers, as well as applicable
contractor staff.
C. The authority delegated to the AA/
OCA is redelegated to the specific
positions designated herein as follows:
1. Loan Specialists, SBA loan centers:
a. Reviewing Loan Specialist:
i. To review all documentation
submitted by the borrower and lender in
connection with a PPP loan and to
request additional information from the
borrower or lender as necessary to
complete the SBA loan review in
accordance with PPP requirements.
ii. To make a recommendation to the
Approving Loan Specialist as to
whether the borrower was eligible for
the PPP loan; was eligible for the PPP
loan amount received, or used the PPP
loan proceeds for authorized purposes;
and/or is eligible for PPP loan
forgiveness and in what amount.
b. Approving Loan Specialist:
i. To review and concur with the
Reviewing Loan Specialist’s
recommendation in paragraph 1.a.ii.
above and make the final SBA loan
review decision, except in the
circumstances described in
subparagraph b.ii. below.
ii. To escalate to the Higher Authority
Review Team all recommendations
when:
(1) The Approving Loan Specialist
and Reviewing Loan Specialist agree
that loan forgiveness will be denied in
whole or in part; and
(2) The Approving Loan Specialist
does not concur with the Reviewing
Loan Specialist’s recommendation,
including when the Approving Loan
Specialist and Reviewing Loan
Specialist disagree on the amount of
loan forgiveness the borrower is entitled
to receive.
2. Higher Authority Review Team:
a. This team will consist of more
experienced employees from the SBA
loan centers.
b. This team will have the authority
to perform Higher Authority Reviews
(HAR). This team will also have the
authority to make the final SBA loan
review decision on all loan reviews
escalated to the team unless the HAR
team escalates a loan review to the
Office of Capital Access Committee in
accordance with paragraph 2.c. below.
The Higher Authority Review will
consist of separate reviews by a
Reviewing Loan Specialist and an
Approving Loan Specialist.
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
c. The HAR team, at their discretion,
will have the authority, on a case-bycase basis, to escalate a loan review to
the Office of Capital Access Committee
for the final SBA loan review decision.
3. To the Office of Capital Access
(OCA) Committee:
a. This committee will consist of the
Director, Office of Financial Assistance
(or designee); the Director, Office of
Credit Risk Management (or designee);
and the career Deputy Associate
Administrator (DAA), Office of Capital
Access (or designee).
b. The OCA Committee will have the
authority to review and make a final
SBA loan review decision, upon a
majority vote of its members, on all loan
reviews that are escalated after the
Higher Authority Review.
II. Except for actions involved in the
denial of liability on a guaranty
purchase request submitted on a PPP
loan and the decision to approve the
initiation of a lawsuit to recover funds
on a PPP loan from a PPP lender or
borrower, the authorities delegated
herein to the AA/OCA may be redelegated. All other authority delegated
herein to anyone other than the AA/
OCA may not be re-delegated, except by
the AA/OCA.
III. The Administrator of the SBA,
Isabella Casillas Guzman, pursuant to
the authority vested in her by the Small
Business Act, 15 U.S.C. 631, as
amended, hereby delegates the
following authorities related to SBA’s
Coronavirus Disease 2019 (COVID–19)
Economic Injury Disaster Loans (COVID
EIDLs) under section 7(b)(2) of the
Small Business Act (15 U.S.C. 636(b)(2))
and section 1110 of the Coronavirus
Aid, Relief, and Economic Security Act
(CARES Act) (Pub. L. 116–136), as
amended, and EIDL Advances,
including Targeted EIDL Advances and
Supplemental Targeted Advances under
section 1110 of the CARES Act, as
amended, section 331 of the Economic
Aid to Hard-Hit Small Businesses,
Nonprofits, and Venues Act (Pub. L.
116–260), and section 5002 of the
American Rescue Plan Act of 2021 (Pub.
L. 117–2):
A. To the Associate Administrator for
the Office of Capital Access (AA/OCA):
1. To establish and revise policies
regarding the eligibility for and
processing of COVID EIDL loans and
EIDL Advances.
2. To procure supplies or services in
support of the COVID EIDL loan and
EIDL Advance programs, and in
accordance with 41 U.S.C. 4701(a) and
(b), as amended, the Federal Acquisition
Regulations, SBA regulations, and
applicable procurement policies.
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
3. This authority may not be
redelegated.
IV. The authorities delegated to any
position indicated herein may be
exercised by any SBA employee
officially designated as Acting in that
position.
V. The authorities delegated herein
can only be revoked or amended by the
Administrator and in writing.
Authority: 15 U.S.C. 631; 15 U.S.C.
636(a)(36); 15 U.S.C. 636(a)(37); 15
U.S.C. 636(b)(2); 15 U.S.C. 636m; Sec.
1110, Pub. L. 116–136, 134 Stat. 281;
Sec. 331, Pub. L. 116–260; and Sec.
5002, Pub. L. 117–2, 135 Stat. 4.
Isabella Casillas Guzman,
Administrator.
[FR Doc. 2021–24908 Filed 11–15–21; 8:45 am]
BILLING CODE 8026–03–P
OFFICE OF THE UNITED STATES
TRADE REPRESENTATIVE
Notice of Product Exclusion
Extensions: China’s Acts, Policies, and
Practices Related to Technology
Transfer, Intellectual Property, and
Innovation
Office of the United States
Trade Representative (USTR).
ACTION: Notice.
AGENCY:
In prior notices, the U.S.
Trade Representative modified the
action in the Section 301 investigation
of China’s acts, policies, and practices
related to technology transfer,
intellectual property, and innovation by
excluding from additional duties certain
medical-care products needed to
address the COVID–19 pandemic. The
99 exclusions for medical care products
to address COVID–19 were published on
December 29, 2020, and are scheduled
to expire on November 14, 2021. On
August 27, 2021, USTR requested
comments on whether to extend the
COVID exclusions. This notice
announces the U.S. Trade
Representative’s determination to
provide a 16-day transition period for
all COVID exclusions (through
November 30, 2021), and to extend 81
of the COVID exclusions for an
additional 6 months.
DATES: To provide a transition period,
this notice extends the 99 exclusions
scheduled to expire on November 14,
2021, through November 30, 2021.
Those exclusions receiving further
extensions will expire six months after
November 30, 20201, on May 31, 2022.
U.S. Customs and Border Protection will
issue instructions on entry guidance and
implementation.
SUMMARY:
E:\FR\FM\16NON1.SGM
16NON1
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
For
general questions about this notice,
contact Associate General Counsel
Philip Butler or Assistant General
Counsel Rachel Komito at (202) 395–
5725. For specific questions on customs
classification or implementation of the
product exclusions, contact
traderemedy@cbp.dhs.gov.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
lotter on DSK11XQN23PROD with NOTICES1
A. Background
In the course of this investigation the
U.S. Trade Representative imposed
additional duties on products of China
in four tranches. See 83 FR 28719 (June
20, 2018); 83 FR 40823 (August 16,
2018); 83 FR 47974 (September 21,
2018), as modified by 83 FR 49153
(September 28, 2018); and 84 FR 43304
(August 20, 2019), as modified by 84 FR
69447 (December 18, 2019) and 85 FR
3741 (January 22, 2020).
For each tranche, the U.S. Trade
Representative established a process by
which U.S. stakeholders could request
the exclusion of particular products
subject to the action. The U.S. Trade
Representative later established a
process by which U.S. stakeholders
could request the extension of particular
exclusions. Additionally, on March 25,
2020, the U.S. Trade Representative
requested public comments on possible
further modifications to remove Section
301 duties from medical-care products
to address the COVID–19 pandemic. 85
FR 16987.
On December 29, 2020, USTR
announced the extension of 80 product
exclusions on medical-care and/or
COVID response products; further
modifications in the form of 19 product
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
exclusions to remove Section 301 duties
from additional medical-care and/or
COVID response products; and that
USTR might consider further extensions
and/or modifications as appropriate. See
85 FR 85831 (the December 29 notice).
On March 10, 2021, USTR announced
the extension of these 99 exclusions
until September 30, 2021, and that
USTR might consider further extensions
and/or modifications as appropriate. 86
FR 13785. On August 27, 2021, USTR
published a notice requesting public
comments on whether any of these
exclusions should be further extended
for up to six months. 86 FR 48280 (the
August 27 notice). The August 27 notice
stated that USTR would evaluate each
exclusion on a case-by-case basis and
the evaluation would examine whether
the exclusion remains appropriate in
light of recent developments including
the spread of the Delta variant in the
United States and increased domestic
production of certain products, and
taking account of the overall impact of
these exclusions on the goal of obtaining
the elimination of China’s acts, policies,
and practices covered in this Section
301 investigation.
On September 29, 2021, USTR
announced the interim extension of
these 99 exclusions through November
14, 2021, in order to provide time to
review public comments submitted in
response to the August 27 notice. 86 FR
54011.
B. Determination To Extend Certain
Exclusions
Based on evaluation of the factors set
out in in the August 27 notice, and
pursuant to sections 301(b), 301(c), and
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
63439
307(a) of the Trade Act of 1974, as
amended, the U.S. Trade Representative
has determined to extend certain
product exclusions described in the
December 29 notice for six months past
the expiry of the remaining exclusions
(until May 31, 2022), as set out in the
annexes to this notice. The U.S. Trade
Representative’s determination
considers public comments submitted
in response to the August 27 notice, and
the advice of advisory committees, the
interagency Section 301 Committee, and
the White House COVID–19 Response
Team.
To provide a transition period for the
expiring exclusions, the U.S. Trade
Representative has determined to
extend all 99 product exclusions
described in the December 29 notice
through November 30, 2021.
The exclusion extensions are
available for any product that meets the
description in the product exclusion.
Further, the scope of each exclusion and
modification is governed by the scope of
the ten-digit Harmonized Tariff
Schedule of the United States (HTSUS)
subheadings and product descriptions
in the annexes to this notice. U.S.
Customs and Border Protection will
issue instructions on entry guidance and
implementation.
The U.S. Trade Representative may
continue to consider further extensions
and/or additional modifications as
appropriate.
Greta Peisch,
General Counsel, Office of the United States
Trade Representative.
BILLING CODE 3290–F2–P
E:\FR\FM\16NON1.SGM
16NON1
63440
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
Annex for COVID Extensions
Annex A
Effective with respect to goods entered for consumption, or withdrawn from warehouse
for consumption, on or after 12:01 a.m. eastern daylight time on November 15, 2021, and
before 11 :59 p.m. eastern daylight time on November 30, 2021, each of the article
descriptions of headings 9903.88.62, 9903.88.63, 9903.88.64 and 9903.88.65 of the
Harmonized Tariff Schedule of the United States are modified by deleting "November
14, 2021," and by inserting "November 30, 2021," in lieu thereof.
Annex B
A. Effective with respect to goods entered for consumption, or withdrawn from
warehouse for consumption, on or after 12:01 a.m. eastern daylight time on
December 1, 2021 and before 11 :59 p.m. eastern daylight time on May 31, 2022,
sub chapter III of chapter 99 of the Harmonized Tariff Schedule of the United States
(HTSUS) is modified:
1. by inserting the following new heading 9903.88.66 in numerical sequence, with the
material in the new heading inserted in the columns of the HT SUS labeled
"Heading/Subheading", "Article Description", and "Rates of Duty I-General",
respectively:
Heading/
Subheading
11
9903.88.66
Article Description
Effective with respect to entries on or after
December 1, 2021, and before June 1, 2022,
articles the product of China, as provided for in
U.S. note 20(sss) to this subchapter, each
covered by an exclusion granted by the U.S.
Trade Representative .....
Rates of Duty
1
General
Special
The duty
provided in
the
applicable
subheading"
2
2. by inserting the following new U.S. note 20(sss) to subchapter III of chapter 99 in
numerical sequence:
(1) Disposable plastic filters of a kind suitable for filtering and dehumidifying a
patient's breath in a medical device such as a gas analyzer ( described in
statistical reporting number 8421.39.8090)
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
PO 00000
Frm 00112
Fmt 4703
Sfmt 4725
E:\FR\FM\16NON1.SGM
16NON1
EN16NO21.219</GPH>
lotter on DSK11XQN23PROD with NOTICES1
"(sss) (i) The U.S. Trade Representative determined to establish a process by which
particular products classified in heading 9903.88.01 and provided for in U.S. notes 20(a)
and 20(b) to this subchapter could be excluded from the additional duties imposed by
heading 9903.88.01. See 83 Fed. Reg. 40823 (August 16, 2018) and 83 Fed. Reg. 47326
(September 18, 2018). Pursuant to the product exclusion process, the U.S. Trade
Representative has determined that, as provided in heading 9903.88.66, the additional
duties provided for in heading 9903.88.01 shall not apply to the following particular
products, which are provided for in the enumerated statistical reporting numbers:
63441
(2) S-band and X-band linear accelerators designed for use in radiation surgery or
radiation therapy equipment (described in statistical reporting number
8543.10.0000)
(3) Disposable electrocardiograph (ECG) electrodes (described in statistical
reporting number 9018.11.9000)
(4) Ultrasonic scanning apparatus, each having dimensions not exceeding 122 cm
by 77 cm by 127 cm, whether or not presented with transducer (described in
statistical reporting number 9018.12.0000)
(5) Blood pressure monitors suitable for use by medical professionals (described in
statistical reporting number 9018.19.9530)
(6) Digital peak flow meters suitable for use by medical professionals (described in
statistical reporting number 9018.19.9550)
(7) Fingertip pulse oximeters suitable for use by medical professionals (described in
statistical reporting number 9018.19.9550)
(8) Bismuth germanate crystals with set dimensional and smface finish
requirements and used as a detection element in Positron Emission Tomography
(PET) detectors (described in statistical reporting number 9018.19.9560)
(9) Magnetic resonance imaging ("MRI") patient enclosure devices, each
incorporating radio frequency and gradient coils (described in statistical
reporting number 9018.19.9560)
(l0)Parts and accessories of capnography monitors (described in statistical reporting
number 9018.19.9560)
(l l)Disposable surface electrodes for Intra-operative neuromonitoring ("IONM")
systems, each composed of a surface electrode pad, an insulated wire, and a
standard DIN 42802 connector ( described in statistical reporting number
9018.19.9560)
(12)Otoscopes (described in statistical reporting number 9018.90.2000)
(13)Anesthesia masks (described in statistical reporting number 9018.90.3000)
(14) Anesthetic instruments and appliances suitable for use in medical or surgical
sciences, and parts and accessories of the foregoing (described in statistical
reporting number 9018.90.3000)
(15)Electrosurgical cautery pencils with electrical connectors (described in statistical
reporting number 9018.90.6000)
(16)Printed circuit board assemblies designed for use in displaying operational
performance of medical infusion equipment (described in statistical reporting
number 9018.90.7580)
(17) Combined positron emission tomography/computed tomography (PET/CT)
scanners which utilize multiple PET gantries (frames) on a common base
(described in statistical reporting number 9022.12.0000)
(18)X-ray tables (described in statistical reporting number 9022.90.2500)
(19)X-ray tube housings and parts thereof (described in statistical reporting number
9022. 90.4000)
(20)Multi-leaf collimators of radiotherapy systems based on the use of X-ray
(described in statistical reporting number 9022.90.6000)
(21) Parts and accessories, of metal, for mobile X-ray apparatus (described in
statistical reporting number 9022.90.6000)
(22) Vertical stands specially designed to support, contain or adjust the movement of
X-ray digital detectors, or the X-ray tube and collimator in complete X-ray
diagnostic systems (described in statistical reporting number 9022.90.6000)
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
PO 00000
Frm 00113
Fmt 4703
Sfmt 4725
E:\FR\FM\16NON1.SGM
16NON1
EN16NO21.220</GPH>
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
63442
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
(23) Thermoplastic masks of polycaprolactone for the use of immobilizing patients,
during the use of alpha, beta or gamma radiations, for radiography or
radiotherapy (described in statistical reporting number 9022.90.9500)
(24) Inoculator sets of plastics, each consisting of a plate with multiple wells, a
display tray, and a lid; when assembled, the set measuring 105 mm or more but
not exceeding 108 mm in width, 138 mm or more but not exceeding 140 mm in
depth, and 6.5 mm or less in thickness (described in statistical reporting number
9027.90.5650)
(ii) The U.S. Trade Representative determined to establish a process by which particular
products classified in heading 9903.88.02 and provided for in U.S. notes 20(c) and 20(d)
to this subchapter could be excluded from the additional duties imposed by heading
9903.88.02. See 83 Fed. Reg. 40823 (August 16, 2018) and 83 Fed. Reg. 47326
(September 18, 2018). Pursuant to the product exclusion process, the U.S. Trade
Representative has determined that, as provided in heading 9903.88.66, the additional
duties provided for in heading 9903.88.02 shall not apply to the following particular
products, which are provided for in the enumerated statistical reporting numbers:
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(iii) The U.S. Trade Representative determined to establish a process by which particular
products classified in heading 9903.88.03 and provided for in U.S. notes 20(e) and 20(f)
to this subchapter could be excluded from the additional duties imposed by heading
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
PO 00000
Frm 00114
Fmt 4703
Sfmt 4725
E:\FR\FM\16NON1.SGM
16NON1
EN16NO21.221</GPH>
lotter on DSK11XQN23PROD with NOTICES1
(9)
9025.19.8010
9025.19.8020
9025.19.8060
9025.19.8085
Molded acrylonitrile-butadiene-styrene (ABS) tubes, of a kind used to effect the
sterile transfer of fluid from a bag or vial to another container, each tube
measuring 7.5 cm or more but not exceeding 23 cm in length, with an inner
diameter of less than 0.65 cm and an outer diameter of less than 9 cm, one end
having been angle-cut to form a spike, and having an integrated flange, less than
3 cm in diameter (splash guard) near the spike end and removable polyethylene
caps on each end, put up in sterile packing ( described in statistical reporting
number 3917.29.0090)
Rectangular sheets of high-density or low-density polyethylene, 111.75 cm to
215.9 cm in width, and 152.4 cm to 304.8 cm in length, with a sticker attached
to mark the center of each sheet, of a kind used in hospital or surgery center
operating rooms (described in statistical reporting number 3920.10.0000)
Sheets and strips consisting of both cross-linked polyethylene and ethylene vinyl
acetate, of a width greater than 1 m but not greater than 1.5 m, and a length
greater than 1.75 m but not greater than 2.6 m (described in statistical reporting
number 3921.19.0000)
Polyethylene sheet and film laminated with spunbond-spunbond-spunbond
nonwoven polypropylene fabric, measuring 1.12 m or more but not over 1.52 m
in width and 1.93 m or more but not over 2.29 min length, and weighing 55
g/m2 or more but not exceeding 88 g/m 2 ( described in statistical reporting
number 3921.90.1500)
Dispensers of hand-cleaning or hand-sanitizing solutions, whether employing a
manual pump or a proximity-detecting battery-operated pump, each article
weighing not more than 3 kg (described in statistical reporting number
8424.89.9000)
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
63443
(1) 3808.94.1000
(2) 3808.94.5010
(3) 3923.21.0095
(4) 3926.20.9050
(5) 4819.50.4060
(6) 5603.12.0090
(7) 5603.14.9090
(8) 5603.92.0090
(9) 5603.93.0090
(10)6505.00.8015
(11)8424.90.9080
(12) Sodium metal (CAS No. 7440-23-5), in bulk solid form (described in statistical
reporting number 2805.11.0000)
(13)Disposable cloths of nonwoven textile materials impregnated, coated or covered
with organic surface-active preparations for washing the skin, put up for retail
sale (described in statistical reporting number 3401.30.5000)
(14)Mixtures containing 2-(dimethylamino)ethanol (CAS No. 108-01-0) (described
in statistical reporting number 3824.99.9297)
(15) Silicon monoxide (SiO) (CAS No. 10097-28-6) in powder form (described in
statistical reporting number 3824.99.9297)
(16)Flexible gas sampling tubes, pipes and hoses, of polyvinyl chloride, with lock
connectors at each end (described in statistical reporting number 3917.33.0000)
(17)Flexible oxygen tubes, pipes and hoses presented with integrated molded
connectors, of polyvinyl chloride ( described in statistical reporting number
3917.33.0000)
(18)Container units of plastics, each comprising a tub and lid therefore, configured
or fitted for the conveyance, packing, or dispensing of wet wipes (described in
statistical reporting number 3923.10.9000)
(19) Sacks and bags of polymers of ethylene, reclosable, qualifying as Class 1
medical devices by the U.S. Food and Drug Administration under product code
NN1 (described in statistical reporting number 3923.21.0030)
(20)Injection molded polypropylene plastic caps or lids each weighing not over 24
grams designed for dispensing wet wipes (described in statistical reporting
number 3923.50.0000)
(21)Hand pumps (other than for fuel or lubricants, not fitted or designed to be fitted
with a metering device), each used to dispense a metered quantity ofliquid soap
or sanitizer (described in statistical reporting number 8413.20.0000)
(22)Hand pumps forliquids (other than those of subheading 8413.11 or 8413.19) of
acrylonitrile butadiene styrene (ABS) plastics (described in statistical reporting
number 8413.20.0000)
(23)Indicator panels incorporating LEDs, designed for use in medical infusion
equipment (described in statistical reporting number 8531.20.0040)
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
PO 00000
Frm 00115
Fmt 4703
Sfmt 4725
E:\FR\FM\16NON1.SGM
16NON1
EN16NO21.222</GPH>
lotter on DSK11XQN23PROD with NOTICES1
9903.88.03, and by which particular products classified in heading 9903.88.04 and
provided for in U.S. note 20(g) to this subchapter could be excluded from the additional
duties imposed by heading 9903.88.04. See 83 Fed. Reg. 47974 (September 21, 2018)
and 84 Fed. Reg. 29576 (June 24, 2019). Pursuant to the product exclusion process, the
U.S. Trade Representative has determined that, as provided in heading 9903.88.66, the
additional duties provided for in heading 9903.88.03 or in heading 9903.88.04 shall not
apply to the following particular products, which are provided for in the enumerated
statistical reporting numbers:
63444
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
(24)Data input devices each with display capabilities of a kind used for magnetic
resonance imaging ("MRf') equipment, computed tomography ("CT")
equipment, intraoperative X-ray ("IXR") equipment or patient monitors
(described in statistical reporting number 8537.10.9170)
(25) Compound binocular optical microscopes (other than stereoscopic microscopes
and microscopes for photomicrography, cinemicrography or microprojection),
each with magnification of 40X or more but not exceeding 1,000X, weighing
not more than 3 kg (described in statistical reporting number 9011.80.0000)
(26) Compound optical microscopes (other than stereoscopic microscopes and
microscopes for photomicrography, cinemicrography or microprojection), each
with magnification of 40X or more but not exceeding 400X, weighing not more
than 15 kg (described in statistical reporting number 9011.80.0000)
(1) 3401.19.0000
(2) 3926.90.9910
(3) 4818.90.0000 prior to July 1, 2020; 4818.90.0020 or4818.90.0080 effective
July 1, 2020
(4) 5210.11.4040
(5) 5210.11.6020
(6) 5504.10.0000
(7) 6210.10.5010
(8) 6210.10.5090
(9) 6307.90.7200
(l0)Face shields of transparent plastics, whether or not assembled (described in
statistical reporting number 3926.90.9950)
(1 l)Bowls of molded plastics, with clips for retaining guide wires during surgical
procedures (described in statistical reporting number 3926.90.9990 prior to July
1, 2020; described in statistical reporting number 3926.90.9985 effective July 1,
2020)
(12) Coverings, of plastics, designed to fit over wound sites or casts thereby forming
a protective seal for keeping the covered area dry and debris free while
showering or bathing (described in statistical reporting number 3926.90.9990
prior to July 1, 2020; described in statistical reporting number 3926.90.9985
effective July 1, 2020)
(13)Disposable graduated medicine dispensing cups of plastics (described in
statistical reporting number 3926.90.9990 prior to July 1, 2020; described in
statistical reporting number 3926.90.9985 effective July 1, 2020)
(14) Single-use sterile drapes and covers of plastics, of a kind used to protect the
sterile field in surgical operating rooms (described in statistical reporting
number 3926.90.9990 prior to July 1, 2020; described in statistical reporting
number 3926.90.9985 effective July 1, 2020)
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
PO 00000
Frm 00116
Fmt 4703
Sfmt 4725
E:\FR\FM\16NON1.SGM
16NON1
EN16NO21.223</GPH>
lotter on DSK11XQN23PROD with NOTICES1
"(iv) The U.S. Trade Representative determined to establish a process by which particular
products classified in heading 9903.88.15 and provided for in U.S. notes 20(r) and (s) to
this subchapter could be excluded from the additional duties imposed by heading
9903.88.15. See 84 Fed. Reg. 43304 (August 20, 2019), 84 Fed. Reg. 45821 (August 30,
2019), 84 Fed. Reg. 57144 (October 24, 2019) and 85 Fed. Reg. 3741 (January 22, 2020).
Pursuant to the product exclusion process, the U.S. Trade Representative has determined
that, as provided in heading 9903.88.66, the additional duties provided for in heading
9903.88.15 shall not apply to the following particular products, which are provided for in
the following enumerated statistical reporting numbers:
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
63445
(15) Sterile decanters of polystyrene plastics, each of a kind used to transfer aseptic
fluids or medication to and from sterile bags, vials or glass containers (described
in statistical reporting number 3926.90.9990 prior to July 1, 2020; described in
statistical reporting number 3926.90.9985 effective July 1, 2020)
(16)Cold packs consisting of a single-use, instant, endothermic chemical reaction
cold pack combined with a textile exterior lining (described in statistical
reporting number 6307.90.9889 prior to July 1, 2020; described in statistical
reporting number 6307.90.9891 effective July 1, 2020)
(17)Hot packs of textile material, single-use (exothermic chemical reaction)
(described in statistical reporting number 6307.90.9889 prior to July 1, 2020;
described in statistical reporting number 6307.90.9891 effective July 1, 2020)
(18)Laparotomy sponges of cotton (described in statistical reporting number
6307.90.9889 prior to July 1, 2020; described in statistical reporting number
6307.90.9891 effective July 1, 2020)
( 19) Single-use blood pressure cuff sleeves of textile materials (described in
statistical reporting number 6307.90.9889 prior to July 1, 2020; described in
statistical reporting number 6307.90.9891 effective July 1, 2020)
(20) Single-use stethoscope covers (described in statistical reporting number
6307.90.9889 prior to July 1, 2020; described in statistical reporting number
6307.90.9891 effective July 1, 2020)
(21) Woven gauze sponges of cotton in square or rectangular sizes (described in
statistical reporting number 6307.90.9889 prior to July 1, 2020; described in
statistical reporting number 6307.90.9891 effective July 1, 2020)
(22) Protective Articles (described in statistical reporting number 9004.90.0000 prior
to January 1, 2021; described in statistical reporting number 9004.90.0010 or
9004.90.0090 effective January 1, 2021)".
3. by amending the last sentence of the first paragraph of U.S. note 20(a) to subchapter
III of chapter 99 by:
a. by deleting "or (13)" and by inserting "(13)" in lieu thereof; and
b. by inserting"; or (14) heading 9903.88.66 and U.S. note 20(sss)(i) to subchapter
III of chapter 99" after the phrase "U.S. note 20(ooo) to subchapter III of chapter
99", where it appears at the end of the sentence.
4. by amending U.S. note 20(b) to subchapter III of chapter 99 by:
a. by deleting "or (13)" and by inserting "(13)" in lieu thereof; and
5. by amending the last sentence of the first paragraph of U.S. note 20(c) to subchapter
III of chapter 99 by:
a. by deleting "or (7)" and by inserting "(7)" in lieu thereof; and
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
PO 00000
Frm 00117
Fmt 4703
Sfmt 4725
E:\FR\FM\16NON1.SGM
16NON1
EN16NO21.224</GPH>
lotter on DSK11XQN23PROD with NOTICES1
b. by inserting"; or (14) heading 9903.88.66 and U.S. note 20(sss)(i) to subchapter
III of chapter 99" after the phrase "U.S. note 20(ooo) to subchapter III of chapter
99", where it appears at the end of the sentence.
63446
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
b. by inserting"; or (8) heading 9903.88.66 and U.S. note 20(sss)(ii) to subchapter
III of chapter 99" after the phrase "U.S. note 20(ppp) to sub chapter III of chapter
99", where it appears at the end of the sentence.
6. by amending U.S. note 20(d) to subchapter III of chapter 99 by:
a. by deleting "or (7)" and by inserting "(7)" in lieu thereof; and
b. by inserting"; or (8) heading 9903.88.66 and U.S. note 20(sss)(ii) to
sub chapter III of chapter 99" after the phrase "U.S. note 20(ppp) to
sub chapter III of chapter 99", where it appears at the end of the sentence.
7. by amending the last sentence of the first paragraph of U.S. note 20(e) to subchapter
III of chapter 99 by:
a. by deleting "or (16)" and by inserting "(16)" in lieu thereof; and
b. by inserting"; or (17) heading 9903.88.66 and U.S. note 20(sss)(iii) to subchapter
III of chapter 99" after the phrase "U.S. note 20(qqq) to subchapter III of chapter
99", where it appears at the end of the sentence.
8. by amending U.S. note 20(f) to subchapter III of chapter 99 by:
a. by deleting "or (16)" and by inserting "(16)" in lieu thereof; and
b. by inserting"; or (17) heading 9903.88.66 and U.S. note 20(sss)(iii) to subchapter
III of chapter 99" after the phrase "U.S. note 20(qqq) to subchapter III of chapter
99", where it appears at the end of the sentence.
9. by amending the last sentence of the first paragraph of U.S. note 20(r) to subchapter
III of chapter 99:
a.
by deleting "or (10)" and by inserting "(10)" in lieu thereof; and
b.
by inserting", or (11) heading 9903.88.66 and U.S. note 20(sss)(iv) to subchapter
III of chapter 99" after "U.S. note 20(m) to sub chapter III of chapter 99".
10. by amending the article description of heading 9903.88.01:
a.
by deleting "9903.88.60 or'';
b.
by inserting in lieu thereof "9903.88.60,"; and
c.
by inserting "or 9903.88.66," after "9903.88.62,".
a. by deleting "9903.88.61 or";
b. by inserting in lieu thereof"9903.88.61,"; and
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
PO 00000
Frm 00118
Fmt 4703
Sfmt 4725
E:\FR\FM\16NON1.SGM
16NON1
EN16NO21.225</GPH>
lotter on DSK11XQN23PROD with NOTICES1
11. by amending the article description of heading 9903.88.02:
Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
63447
c. by inserting "or 9903.88.66," after "9903.88.63,".
12. by amending the article description of heading 9903.88.03:
a. by deleting "9903.88.56 or'';
b. by inserting in lieu thereof "9903.88.56,"; and
c. by inserting "or 9903.88.66," after "9903.88.64,".
13. by amending the article description of heading 9903.88.04:
a. by deleting "9903.88.56 or'';
b. by inserting in lieu thereof "9903.88.56," ; and
c. by inserting "or 9903.88.66" after "9903.88.64".
14. by amending the article description of heading 9903.88.15:
a. by deleting "9903.88.57 or" and by inserting "9903.88.57," in lieu thereof; and
b. by inserting "or 9903.88.66," after "9903.88.65,".
DEPARTMENT OF TRANSPORTATION
Federal Aviation Administration
[Summary Notice No. 2021–0004]
Petition for Exemption; Summary of
Petition Received; Skyways Air
Transportation, Inc.
Federal Aviation
Administration (FAA), Department of
Transportation (DOT).
ACTION: Notice.
AGENCY:
This notice contains a
summary of a petition seeking relief
from specified requirements of Federal
Aviation Regulations. The purpose of
this notice is to improve the public’s
awareness of, and participation in, the
FAA’s exemption process. Neither
publication of this notice nor the
inclusion or omission of information in
the summary is intended to affect the
legal status of the petition or its final
disposition.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
Comments on this petition must
identify the petition docket number and
must be received on or before December
6, 2021.
VerDate Sep<11>2014
17:03 Nov 15, 2021
Jkt 256001
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
Docket: Background documents or
comments received may be read at
https://www.regulations.gov at any time.
Follow the online instructions for
accessing the docket or go to the Docket
Operations in Room W12–140 of the
West Building Ground Floor at 1200
New Jersey Avenue SE, Washington, DC
20590–0001, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal
holidays.
FOR FURTHER INFORMATION CONTACT: Jake
Troutman, (202) 683–7788, Office of
Rulemaking, Federal Aviation
Administration, 800 Independence
Avenue SW, Washington, DC 20591.
This notice is published pursuant to
14 CFR 11.85.
Issued in Washington, DC.
Caitlin Locke,
Acting Executive Deputy Director, Office of
Rulemaking.
Petition for Exemption
Docket No.: FAA–2020–1190.
Petitioner: Skyways Air
Transportation, Inc.
Section(s) of 14 CFR Affected:
§§ 61.113(a) & (b); 91.7(a); 91.109;
91.119(c); 91.121(a)(1); 91.405(a);
91.407(a)(1); 91.409(a)(1) & (2); 91.417(a)
& (b).
Description of Relief Sought: Skyways
Air Transportation, Inc. (Skyways) seeks
relief to operate the Skyways V2.50
E:\FR\FM\16NON1.SGM
16NON1
EN16NO21.226</GPH>
BILLING CODE 3290–F2–C
DATES:
Send comments identified
by docket number FAA–2020–1190
using any of the following methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov and follow
the online instructions for sending your
comments electronically.
• Mail: Send comments to Docket
Operations, M–30; U.S. Department of
Transportation, 1200 New Jersey
Avenue SE, Room W12–140, West
Building Ground Floor, Washington, DC
20590–0001.
• Hand Delivery or Courier: Take
comments to Docket Operations in
Room W12–140 of the West Building
Ground Floor at 1200 New Jersey
Avenue SE, Washington, DC 20590–
0001, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal
holidays.
• Fax: Fax comments to Docket
Operations at (202) 493–2251.
Privacy: In accordance with 5 U.S.C.
553(c), DOT solicits comments from the
public to better inform its rulemaking
process. DOT posts these comments,
without edit, including any personal
information the commenter provides, to
https://www.regulations.gov, as
described in the system of records
notice (DOT/ALL–14 FDMS), which can
be reviewed at https://www.dot.gov/
privacy.
ADDRESSES:
[FR Doc. 2021–24918 Filed 11–15–21; 8:45 am]
]]>Agencies
[Federal Register Volume 86, Number 218 (Tuesday, November 16, 2021)]
[Notices]
[Pages 63438-63447]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24918]
=======================================================================
-----------------------------------------------------------------------
OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE
Notice of Product Exclusion Extensions: China's Acts, Policies,
and Practices Related to Technology Transfer, Intellectual Property,
and Innovation
AGENCY: Office of the United States Trade Representative (USTR).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In prior notices, the U.S. Trade Representative modified the
action in the Section 301 investigation of China's acts, policies, and
practices related to technology transfer, intellectual property, and
innovation by excluding from additional duties certain medical-care
products needed to address the COVID-19 pandemic. The 99 exclusions for
medical care products to address COVID-19 were published on December
29, 2020, and are scheduled to expire on November 14, 2021. On August
27, 2021, USTR requested comments on whether to extend the COVID
exclusions. This notice announces the U.S. Trade Representative's
determination to provide a 16-day transition period for all COVID
exclusions (through November 30, 2021), and to extend 81 of the COVID
exclusions for an additional 6 months.
DATES: To provide a transition period, this notice extends the 99
exclusions scheduled to expire on November 14, 2021, through November
30, 2021. Those exclusions receiving further extensions will expire six
months after November 30, 20201, on May 31, 2022. U.S. Customs and
Border Protection will issue instructions on entry guidance and
implementation.
[[Page 63439]]
FOR FURTHER INFORMATION CONTACT: For general questions about this
notice, contact Associate General Counsel Philip Butler or Assistant
General Counsel Rachel Komito at (202) 395-5725. For specific questions
on customs classification or implementation of the product exclusions,
contact [email protected].
SUPPLEMENTARY INFORMATION:
A. Background
In the course of this investigation the U.S. Trade Representative
imposed additional duties on products of China in four tranches. See 83
FR 28719 (June 20, 2018); 83 FR 40823 (August 16, 2018); 83 FR 47974
(September 21, 2018), as modified by 83 FR 49153 (September 28, 2018);
and 84 FR 43304 (August 20, 2019), as modified by 84 FR 69447 (December
18, 2019) and 85 FR 3741 (January 22, 2020).
For each tranche, the U.S. Trade Representative established a
process by which U.S. stakeholders could request the exclusion of
particular products subject to the action. The U.S. Trade
Representative later established a process by which U.S. stakeholders
could request the extension of particular exclusions. Additionally, on
March 25, 2020, the U.S. Trade Representative requested public comments
on possible further modifications to remove Section 301 duties from
medical-care products to address the COVID-19 pandemic. 85 FR 16987.
On December 29, 2020, USTR announced the extension of 80 product
exclusions on medical-care and/or COVID response products; further
modifications in the form of 19 product exclusions to remove Section
301 duties from additional medical-care and/or COVID response products;
and that USTR might consider further extensions and/or modifications as
appropriate. See 85 FR 85831 (the December 29 notice). On March 10,
2021, USTR announced the extension of these 99 exclusions until
September 30, 2021, and that USTR might consider further extensions
and/or modifications as appropriate. 86 FR 13785. On August 27, 2021,
USTR published a notice requesting public comments on whether any of
these exclusions should be further extended for up to six months. 86 FR
48280 (the August 27 notice). The August 27 notice stated that USTR
would evaluate each exclusion on a case-by-case basis and the
evaluation would examine whether the exclusion remains appropriate in
light of recent developments including the spread of the Delta variant
in the United States and increased domestic production of certain
products, and taking account of the overall impact of these exclusions
on the goal of obtaining the elimination of China's acts, policies, and
practices covered in this Section 301 investigation.
On September 29, 2021, USTR announced the interim extension of
these 99 exclusions through November 14, 2021, in order to provide time
to review public comments submitted in response to the August 27
notice. 86 FR 54011.
B. Determination To Extend Certain Exclusions
Based on evaluation of the factors set out in in the August 27
notice, and pursuant to sections 301(b), 301(c), and 307(a) of the
Trade Act of 1974, as amended, the U.S. Trade Representative has
determined to extend certain product exclusions described in the
December 29 notice for six months past the expiry of the remaining
exclusions (until May 31, 2022), as set out in the annexes to this
notice. The U.S. Trade Representative's determination considers public
comments submitted in response to the August 27 notice, and the advice
of advisory committees, the interagency Section 301 Committee, and the
White House COVID-19 Response Team.
To provide a transition period for the expiring exclusions, the
U.S. Trade Representative has determined to extend all 99 product
exclusions described in the December 29 notice through November 30,
2021.
The exclusion extensions are available for any product that meets
the description in the product exclusion. Further, the scope of each
exclusion and modification is governed by the scope of the ten-digit
Harmonized Tariff Schedule of the United States (HTSUS) subheadings and
product descriptions in the annexes to this notice. U.S. Customs and
Border Protection will issue instructions on entry guidance and
implementation.
The U.S. Trade Representative may continue to consider further
extensions and/or additional modifications as appropriate.
Greta Peisch,
General Counsel, Office of the United States Trade Representative.
BILLING CODE 3290-F2-P
[[Page 63440]]
[GRAPHIC] [TIFF OMITTED] TN16NO21.219
[[Page 63441]]
[GRAPHIC] [TIFF OMITTED] TN16NO21.220
[[Page 63442]]
[GRAPHIC] [TIFF OMITTED] TN16NO21.221
[[Page 63443]]
[GRAPHIC] [TIFF OMITTED] TN16NO21.222
[[Page 63444]]
[GRAPHIC] [TIFF OMITTED] TN16NO21.223
[[Page 63445]]
[GRAPHIC] [TIFF OMITTED] TN16NO21.224
[[Page 63446]]
[GRAPHIC] [TIFF OMITTED] TN16NO21.225
[[Page 63447]]
[GRAPHIC] [TIFF OMITTED] TN16NO21.226
[FR Doc. 2021-24918 Filed 11-15-21; 8:45 am]
BILLING CODE 3290-F2-C
